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Summary: A specific method for the detection of organic hydroperoxides in lung lavage fluid (lung surfactant
System) and lung tissue homogenate is described. After the inactivation of endogenous GSH peroxidase and
GSH reductase and preincubation with catalase, organic hydroperoxides are consumed by addition of GSH
and GSH peroxidase. The increase of GSSG, compared to a blank without addition of GSH peroxidase, is
measured in a second enzymatic step with GSH reductase. The recoveries of t-butyl hydroperoxide and of
peroxidized, free fatty acids added to lavage fluid or to lung homogenate are higher than 85% in each case.
The detection limits of this assay for organic hydroperoxides are 0.9 nmol/mg surfactant phospholipid (molar
ratio of 0.00066) and 40 nmol/g wet lung weight. The assay detects organic hydroperoxides in the surfactant
System of normal rabbit lungs, but not in lung tissue homogenate.
Messung organischer Hydroperoxide in Kaninchenlungen-Lavageflüssigkeit, aber nicht im Lungengewebe-
Homogenat, mittels GSH-Peroxidase und GSH-Reduktase
Zusammenfassung: Eine spezifische Methode für den Nachweis organischer Hydroperoxide in Lungen-La-
vage-Flüssigkeit (Lungen Surfactant System) und Lungengewebe-Homogenat wird beschrieben. Nach Inakti-
vierung endogener GSH-Peroxidase und GSH-Reduktase und Präinkubation mit Katalase werden organi-
sche Hydroperoxide durch Zusatz von GSH und GSH-Peroxidase metabolisiert. Der Anstieg von GSSG,
verglichen mit einem Leerwert ohne Zusatz von GSH-Peroxidase, wird in einem zweiten enzymatischen
Schritt mit GSH-Reduktase gemessen. Die Wiederfindung von t-Butyl-hydroperoxid und von peroxidierten
freien Fettsäuren nach Zusatz zur Lavage-Flüssigkeit oder zum Gewebe-Homogenat beträgt mehr als 85%.
Die Nachweisgrenze dieses Testes für organische Hydroperoxide liegt bei 0,9 nmol/mg Surfactant-Phospholi-
pid (molares Verhältnis von 0,00066) und 40 nmol/g Feuchtgewebe. Der Test weist organische Hydroperoxi-
de im Surfactänt'System normaler Kaninchenlungen, aber nicht im Gewebehomogenat nach.
Iiitrodüction
There is impressive ex;perimental evidence that qxy-
geii-derived free radicals and (subsequent) peroxi-
dation processes represent a common etiology in
lung injury provoked by exposure to toxic levels of
oxygen (1—3), oxidizing agents such äs NOi and
ozone (4—7) and leukocyte^dependent acute (respi-
ratory distress syndrome) and chronic inflammatory
events (8—10). In bronchoalveolar lavage fluid from
patients with respiratory distress syndrome, obtained
by flexible bronchoscopy, Cochrane et al. observed
the oxidative inactivation of the -proteinase inhib-
itor in this System, thus providing indirect evidence
for the presence of oxidants in vivo (11). The detec-
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tion of lipid peroxidation in biological Systems is
based chiefly on the measurement of their cleavage
products: malonaldehyde by the thiobarbituric acid
reaction (12,13), fluorescent chromophores (14,15)
and recently ethane and pentane by gas chromato-
graphy (16, 17). Direct measurement of peroxides
by UV-detection of conjugated dienes (18, 19) and
titrimetrical measurement of \2 generated from a KI
solution (20, 21) lack specifity in complex biological
Systems. GSH peroxidase (GSH: H2O oxidoreduc-
tase; EC 1.11.1.9) reduces numerous organic hy-
droperoxides to their corresponding alcohols, there-
by transfering two electrons from the oxidation of
GSH to GSSG, which, in a second enzymatic Step, is
again reduced to GSH by NADPH via GSH reduc-
tase (EC 1.6.4.2) (22—26). Preincubation with cata-
lase (EC 1.11.1.6) prior to the addition of GSH pe-
roxidase destroys H2O2, which would otherwise in-
terfere in the determination of organic hydroperox-
ides. Biological materials, however, require certain
precautions because of the lability of organic hy^
droperoxides. When applying this enzymatic assay to
rabbit lung surfactant System, obtained by bron-
choalveolar lavage, and to rabbit lung tissue homo-
genate, it was found to be advantageous to separate
the two enzymatic Steps, transforming the organic
hydroperoxides to their alcohols s soon s possible
in the assay procedure in order to obtain the stable
GSSG. In this way exogenously added organic hy-
droperoxides are recovered >85% from the lavage
fluid and the tissue homogenate. This assay detects
organic hydroperoxides in natural rabbit lung surfac-
tant, but not in lung homogenate.
Materials and Methods
Reagents
Lyophilized GSH peroxidase from bovine erythrocytes (EC
1.11.1.9) was a gift from Dr. Wunderwald, Boehringer Mann-
heim, FRG. The lyophilized material, containing 20% protein
(Biuret), had a specific activity of 0.55 U/mg, measured according
to G nzler et al. (27) (with a modified reaction temperature of
25 °C instead of 37 °C). GSH reductase from yeast (EC 1.6.4.2;
specific activity 120 U/mg protein), catalase from bovine liver
(EC 1.11.1.6; specific activity 65000 U/mg protein), GSH and
NADPH were purchased from Boehringer Marinheim. Lipoxi-
dase from soybean (EC 1.13.11.12; specific activity 500000
U/mg protein) and t-butyl hydroperoxide were obtained from
Sigma.
Methods
The lungs of rabbits of both sexes (body weight 2.2-2.8 kg) were
excised during deep anaesthesia and the blood was completely re-
moved by rinsing the vascular bed with ice-cold saline. Imme-
di ately afterwards the lungs were ei t her homogenized or lavaged
with 4 x 25 ml ice-cold saline via a tracheal canula. The phospho-
lipid content of the lavage fluid was determined from its organic
phosphorus (28), calculated on the basis of the molecular weight
of dipalmitoyl lecithin. It ranged between 250 and 350 mg/1. In
vitro measurement of t-butyl hydroperoxide and peroxidized, free
fatty acids was carried out according to Heath & Tappet (25). A
mixture of peroxidized, free fatty acids from equal molar amounts
of linoleic acid, linolenic acid and arachidonic acid for the mea-
surement of recovery was prepared by incubation with soybean
lipoxidase according to Hamberg & Samuelsson (29). Non-enzy-
matic lipid peroxidation of the alveolar surfactant material was
performed by incubation with FeCls (0.67 mmol/l) and ascorbic
acid (1.33 mmol/l) for 20 h at 37 °C according to Dwnelin & Tap-
pel (30).
Measurement of organic hydroperoxides in the alveo-
lar sur fac tan t System and in lung tissue homogenate
Both assay procedures follow the same principle. Each step is per-
formed with ice-cold lavage fluid and tissue homogenate and ice-
cold reagents if not indicated otherwise.
Lavage
The lavage fluid is centrifuged at 1000g for 5 min (31); Then l
mol/1 perchloric acid is added (0.2 l/l of the cell free lavage vo-
lume) and after 2 min is neutralized (pH 7) with the same Volume
of l mol/1 KOH. After the addition of KH2PO4 buffer (0.25
mol/1; pH 7; 2.5 mmol/l EDTA - 0.1 l/l of the initial lavage vo-
lume) and catalase (780 kU/1 initial lavage volume), the mixture is
allowed to stand for 10 min, followed by addition of 155 mg GSH
per l initial lavage volume. The total volume is then divided into
two identical portions and one portion is incubated t 25 °C with
0.4 g lyophilized GSH peroxidase per l initial lavage volume. The
other portion undergoes the same procedure without addition of
GSH peroxidase. After 20 min incubation both portions are im-
mediately spin-frozen, lyophilized anc} resuspended in a small vo-
lume of distilled water (usually 2 ml) .'The suspensions are extract-
ed with identical volumes of Chloroform, centrifuged briefly and
GSSG is determined in the aqueous phases according to Bergmey-
er (32). The difference in the GSSG concentration between the
two portions of the lavage fluid is used to calculate the amount of
organic hydroperoxides. The data are expressed in nmol/mg lav^
age phospholipid or s the molar ratio of organic hydroperoxides
to phospholipid.
Lung tissue homogenate
Lung tissue is roughly minced and immediately homogenized in
0.5 mol/1 HC1O4 (2 ml/g wet weight; time of homogenization
about 2 min). Then the homogenate is neutralized with 1.75 mol/l
KsPO4 and is incubated with catalase (520 kU/l homogenate vo-
lume) for 5 min. Next GSH is added (0.7 g/l homogenate vo-
lume), the total volume is divided and one portion is incubated at
25 °C with 0.8 g lyophilized GSH peroxidase per l homogenate
fluid for 10 min. The other portion is incubated under the same
conditions but without GSH peroxidase. Then both portions are
immediately cooled to 0 °C, precipitated with 2 mol/1 HC1O4 (0.4
l/l) and centrifuged (4 min, 8000 g). The 8μρβπΐ3ΐ3ηΐ5 are neutral-
ized with 1.75 mol/ϊ Κ3ΡΟ4, centrifuged again (2 min, 8000 g) and
GSSG is determined in both supernatarits according to Bergmeyer
(32). The difference in the concentration of GSSG between the
«two homogenate portions is used to calculate the amount of or-
ganic hydroperoxides. The data are expressed in nmol hydroper^
oxide per g wet lung weight. » ;
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Results
Inac t iva t ion of endogenous enzymes
Incubation of the lavage fluid and the lung tissue
homogenate with ice-cold perchloric acid (final con-
centration 0.2 and 0.33 mol/1 according to the differ-
ent protein concentrations) for 2min and subse-
quent neutralization with KOH or KaPO4 is suffi-
cient to completely inactivate endogenous GSH per-
oxidase and GSH reductase. The samples are not
spun after neutralization, in order to prevent poten-
tial loss of lipid material before "converting" the
amount of hydroperoxides to GSSG by GSH peroxi-
dase. Organic hydroperoxides are not destroyed by
this procedure: t-butyl hydroperoxide and a mixture
of peroxidized free fatty acids are recovered to
>95% when submitted to this reaction Step.
Addi t ion of phosphate b u f f e r
The addition of 0.1 l/l phosphate buffer (0.25 mol/1,
pH 7) to the surfactant system, obtained by lavage
with saline, is necessary for the enzymatic activity of
GSH peroxidase.
Addition of catalase
The addition of 520 kU/1 assay volume is sufficient
for complete degradation of >0.3 mmol/1 H2O2 in 5
min at 0 °C.
Addi t ion of GSH
The amount of GSH added to the lavage fluid and
the tissue homogenate should be 5 fold higher than
the amount of organic hydroperoxides maximally ex-
pected. If the cöiicentration of GSH is too low, the
turnover of hydroperoxides by GSH peroxidäse is
incomplete, whereas excessive concentrations favour
the spontaneous formätion of GSSG. Owing to this
spontaneous oxidation of GSH, the strictly parallel
treatment of the twö portions of a,sample (with and
without GSH peroxidase) is mandatory.
Addition of GSH peroxidase
The concentrations of GSH peroxidase chosen in the
assay procedures are sufficient to guarantee the
complete turnover of >0.1 mmol/1 t-butyl hydroper-
oxide and >0.1 mmol/1 of a mixture of peroxidized,
free fatty acids under the given reaction conditions.
Recovery, sensit ivi ty
The recovery of t-butyl hydroperoxide and of perox-
idized, free fatty acids is listed in table 1. The sensi-
tivity is reasonably high: organic hydroperoxides can
be specifically detected at a cöncentration äs low äs
0.9 nmol/mg lavage phospholipid (molar ratio of
0.00066) and 40 nmol/g wet weight.
Tab. 1. Recovery of t-butyl hydroperoxide and of a mixture of
peroxidized, free fatty acids added to lavage fluid
(25 nmol hydroperoxide per mg lavage phospholipid) and
to fresh lung tissue (600 nmol/g wet weight) immediately
prior to the complete assay procedure. As the time (latent
period) is increased between mixing of peroxidized free
fatty acids with roughly minced lung tissue at 0 °C and the
beginning of the first step of the assay procedure (ho-
mogenation with HC1O4), there is rapid decrease in re-
covery.
Peroxidized t-Butyl
free fatty acids hydro-
peroxide
Lavage fluid
(n = 4; no latent period)
Tissue homogenate
(n = 4; no latent period)
Latent period 5 min (n = 1)
Latent period 10 min (n = 1)
Latent period 30 min (n = 1)
94-100%
89- 94%
91%
76%
14%
86-92%
86-91%
Application to sur fac tan t and lung tissue
with and without peroxidative stress
When the assay was applied to lavages of normal
rabbit lungs, the measured cöncentration of organic
hydroperoxides was 41.7 ±8.6 nmol/mg phospho-
lipid (mean ± S.D.; n = 6). The amount of hydro-
peroxide found in lavages of rabbits which had been
exposed to a 100% oxygen atmosphere for 48 h is
oiily insignificantly higher: 49.7 ± 18.7 nmol/mg
phospholipid (n = 6). If, however, lavages from nor-
mal lungs were exposed to FeCla and ascorbic acid
for 20h (26), the amount of hydroperoxides in-
creased dramatically: 724 ±109 nmol/mg phospho-
lipid, i.e. a molar ratio of 0.53 ± 0.08, was found (n
= 4). When lung tissue homogenate of normal rab-
bits was assayed, no organic hydroperoxides were
detected by the described method (n = 10). Even a
challenge of normal lungs with FeCl3 and ascorbic
acid for 20 h (after homogenization of the tissue with
phosphate buffer or with perchloric acid and subse-
quent neutralization) did not result in detectable
amounts of hydroperoxides (n = 3).
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Discussion
The described assay, employing GSH peroxidase
and GSH reductase, specifically detects exogenously
added organic hydroperoxides in the alveolar surfac-
tant System and in lung tissue homqgenate with good
recovery. The sensitivity is high enough to detect en-
dogenous organic hydroperoxides in the bronchoal-
veolar lavage fluid from normal lungs. The marked
increase of hydroperoxides after incubation of the
surfactant material with FeCl3 and ascorbic acid in
vitro encouraged us to measure hydroperoxide levels
in the surfactant System in situations of increased
peroxidative stress in vivo.
Though GSH peroxidase in general shows broad
specifity towards the hydroperoxide-bearing sub-
strate, there are doubts whether peroxidized fatty
acids in phospholipids are converted by this enzyme
(26). At least the lipoxygenäse accessible regions of
di-linoleoyl-lecithin (regions peroxidized after incu-
bation with soybean lipoxygenase) are a poor sub-
strate for GSH peroxidase (33). In view of this ob-
servation, the high amount of GSH peroxidase de-
tectable hydroperoxides found after FeCl3/ascorbate
incubation of the lavage fluid is surprising. Calcula-
ted in relation to the lavage phospholipids, which ac-
count for >80% of the total lavage lipids (34), a mo-
lar ratio of 0.53 (hydroperoxide per phospholipid) is
found. This suggests that either FeCl3/ascorbate-in-
duced hydroperoxides in phospholipids are better
accessible to the GSH peroxidase, or that this unspe-
cific peroxidation procedure is followed by extensive
fragmentation of the phospholipids.
With respect to lung tissue homogenate, organic hy-
droperoxides cannot be detected even after a masr
sive peroxidative attack with FeCls/ascorbic acid.
Two explanations are offered:
a) Experiments measuring lipid peroxidation by the
thiobarbituric acid method (35,36) have suggest-
ed a cytosolic peroxidation inhibitory factor in
lung tissue. In accordance with these data no
ethane and pentane could be detected in the
headspace of lung tissue homogenate incübated
with FeCls/ascorbate for 20 h (detection limit =
l pmol volatile hydrocarbon1).
b) The described assay measures the "steady state
level" of organic hydroperoxides, which may be
low in lung tissue because of rapid enzymatic or
non-enzymatic degradation. In this cöntext tran-
sition metals and haem groups must be cpiisi-
dered to play a major role (37—39). Rapid per-
oxide decompositiori would also explain the non-
recovery of the surfactant hydroperoxides in the
whole lung homogenate (70—130 nmol/g wet
lung weight were to be expected when calculated
on the basis of the hydroperoxide content of the
lavage fluid), and the rapidly decreasing recovery
of peroxidized fatty acids added to freshly
minced lung tissue, even at 0 °C (tab. 1).
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